Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Generating mammalian T cell activation inducible synthetic promoters (SYN+PRO) to improve T cell therapy

Generating mammalian T cell activation inducible synthetic promoters (SYN+PRO) to improve T cell therapy

US Patent 11851649 · Granted Dec 26, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Truncated epiderimal growth factor receptor (EGFRt) for transduced t cell select2025
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labe2025
Methods of use for CAR T cells2025
Production of engineered T-cells by sleeping beauty transposon coupled with meth2025
Sequencing method for CAR T cell therapy2025
Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD192025
Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD192025
Drug regulated transgene expression2025
Closed-system manufacturing process for CAR-T cells2024
Methods and compositions comprising B7H3 chimeric antigen receptors2024
Nucleic acids encoding IL-13 receptor alpha 2 (IL13Ra2) chimeric antigen recepto2024
Early intervention methods to prevent or ameliorate toxicity2024